Life Sciences Tools and Services
Company Overview of Spaulding Clinical Research, LLC
Spaulding Clinical Research, LLC operates as a Phase I clinical trial facility in Wisconsin. It offers a range of services, including definitive QTc (TQT) studies, first-in-human studies, multiple rising dose, bioavailability and bioequivalence, drug interaction, food effect, PK/PD characterization, and data collection and management. It also offers a suite of cardiac core lab and over-reading services. Spaulding Clinical Research, LLC has a strategic partnership with Clinigene International Limited. The company was incorporated in 2007 and is based in West Bend, Wisconsin.
525 South Silverbrook Drive
West Bend, WI 53095
Founded in 2007
Key Executives for Spaulding Clinical Research, LLC
Founder and Chief Executive Officer
Senior Vice President of Operations and General Manager
Director of Pharmacy Services
Compensation as of Fiscal Year 2016.
Spaulding Clinical Research, LLC Key Developments
Spaulding Clinical Research, LLC Appoints Shane Braninburg as Senior Director of Core Lab Services
Jun 9 16
Spaulding Clinical Research, LLC announced the addition of Shane Braninburg as Senior Director of Core Lab Services. Mr. Braninburg brings more than 15 years of global business expertise to Spaulding, including extensive operational and management experience at two of the large cardiac core labs in the world. Prior to joining the company, Mr. Braninburg was the Senior Director of Business Process Improvement at ERT, where he was responsible for launching ERT's centralized surveillance product across respiratory, cardiac and clinical outcome lines of business. His previous roles at ERT include Senior Director of Site Management and Director of Operations, Digital ECG Laboratory.
Spaulding Clinical Research, LLC Expands Clinical Pharmacology Capabilities
Jul 5 15
Spaulding Clinical Research, LLC announced that the Company had completed an expansion of their Clinical Pharmacology Unit located in West Bend, WI in order to meet growing client demand for expertise-based studies in the early phases of clinical development. SCR’s Clinical Pharmacology Research Unit has been expanding capabilities and capacity for client programs since 2007 when the unit opened. With its most recent expansion, the unit now has 200 beds, representing such facility in the region. The unit is comprised of a 12-bed FIH/ICU Unit and houses 96-beds of telemetry.
Spaulding Clinical Research Adopts Revolutionary ClinSpark™ eSource System
Jun 19 15
Spaulding Clinical Research, LLC announced that they have completed the upgrade of their eSource platform and future capabilities to use Foundry Health, LLC’s ClinSpark™ system, the CDISC ODM certified eSource solution. Spaulding Clinical utilizes the platform from subject recruitment throughout the entire study and data management processes. The significant advantages ClinSpark™ has over competing systems include: The ability to communicate with potential study subjects bi-directionally with SMS (text messages); Multi-site support that allows for deployment to the Cloud or to internal data centers; Extensive cardiac integration with both telemetry and cardiograph ECG systems; True bi-directional interface support of HL7, CDISC LAB, and other standards; Barcode sample specimen management for protocol adherence; Bedside device integration that facilitates automatic data collection from medical devices; Role-specific Dashboards for monitors, investigators or other staff that allows for clear visualizations of study progress; Support for traditional desktop and laptop computers in addition to mobile devices.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|